Ophthalmology

Joseph Coney, MD, FASRS, FACS, discusses the difference between population groups in age-related macular degeneration (AMD) and diabetic macular edema (DME)

Jim Kenney, RPh, MBA, opens a discussion surrounding wet age-related macular degeneration (AMD) and diabetic macular edema (DME).

Disparities in access to pediatric ophthalmological care is associated with lower socioeconomic status.

A recent study has found that the prevalence of vision impairment in US adults 71 years and older was higher in 2021 compared with prior estimates.

Michael Chiang, MD, director of the National Eye Institute, spoke about efforts to address age-related macular degeneration (AMD) as well as health disparities in clinical trials and access to treatment.

Retinal nerve fiber layer (RNFL) thickness has been independently associated with incident cardiovascular disease risks in a new analysis that utilized data from 2 international databases.

Patients who took hydroxychloroquine had an overall risk of hydroxychloroquine retinopathy of 8.6% after 15 years.

Retinal vasculature in peripheral regions of the retina differed in patients with Alzheimer dementia and mild cognitive impairment.

Diagnosing ocular surface diseases could be made easier as artificial intelligence (AI) screening improves.

A clinical trial found that the prevalence of age-related macular degeneration (AMD) was not associated with the use of metformin.

The top 5 most-read content in ophthalmology for 2022 focused on the relationship between aging and visual field reliability, telehealth eye care visits, the link between COVID-19 and dry eye disease, and more.

Coverage of the annual meeting of the American Academy of Ophthalmology (AAO) included interviews with experts on thyroid eye disease and anti–vascular endothelial growth factor therapy, as well as breaking research.

A new study has found that prolonged screen time may cause increased symptoms of dry eye disease (DED) in children.

A retrospective cohort study found that rapid thinning of the ganglion cell complex was associated with central visual field decline.

Meibomian gland dysfunction, an etiological factor of dry eye disease, showed promising results in response to treatment with intense pulsed light.

The risk of age-related macular degeneration (AMD) could be linked to structural variations in the APOE gene that were previously found to be associated with protection against Alzheimer disease.

A report from the World Health Organization highlights the global burden of oral diseases; study shows the predictive value of a “good” cholesterol level varies between Black and White patients; CDC report suggests people with impaired vision are not receiving proper health care.

A study found that dry eye disease (DED) can be separated into 5 subtypes, all of which differed significantly.

A recent study found that patients who had cataract surgery were satisfied overall with discharge teaching quality, were well prepared for discharge, and had good postdischarge outcomes.

A high glaucoma polygenic risk was associated with glaucoma progression in the early stages of primary open-angle glaucoma (POAG).

A decline in eye care utilization was found in older patients, with significant differences based on age, race, and ethnicity.

A quality improvement study found that severe visual impairment was affected by various social determinants of health, including low socioeconomic status, race, and educational level.

Recent FDA approvals and therapies under FDA review are adding new treatments to the armamentarium, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.

The results of a study showing improved functional vision and retinal sensitivity have implications for gene therapy in ophthalmological conditions, explained Michel Michaelides, MD, FACP, a consultant ophthalmologist and a professor of ophthalmology at the University College London Institute of Ophthalmology's Genetics Department.

Patients with uveitis and their physicians may be very familiar with intravitreal injections, but triamcinolone acetonide injectable suspension (Xipere) has a novel delivery method, said Steven Yeh, MD, professor and the Stanley Truhlsen Jr. Chair in Ophthalmology at the Truhlsen Eye Institute, University of Nebraska Medical Center.